ID

24892

Beschrijving

Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease

Trefwoorden

Versies (2)
  1. 22-08-17 22-08-17 -
  2. 04-09-17 04-09-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

22 augustus 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

study medication administration determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

Engels

study medication administration determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 Formulieren  
Administrative Data
Beschrijving

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Initials
Beschrijving

patient's initials

Datatype

text

Alias
UMLS CUI [1]
C2986440
Patient No.
Beschrijving

patient number

Datatype

integer

Alias
UMLS CUI [1]
C1830427
Dose#1
Beschrijving

Dose#1

Alias
UMLS CUI-1
C3174092
Date of Administration
Beschrijving

date of administration

Datatype

date

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0011008
Time of Administration
Beschrijving

24-hour clock

Datatype

time

Alias
UMLS CUI [1]
C1317775
Dose#2
Beschrijving

Dose#2

Alias
UMLS CUI-1
C3174092
Time of Administration
Beschrijving

24-hour clock

Datatype

time

Alias
UMLS CUI [1]
C1317775
Dose#3
Beschrijving

Dose#3

Alias
UMLS CUI-1
C3174092
Time of Administration
Beschrijving

24-hour clock

Datatype

time

Alias
UMLS CUI [1]
C1317775
Terug naar het begin van de pagina

Similar models

study medication administration determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
patient's initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])
Item Group
Dose#1
C3174092 (UMLS CUI-1)
date of administration
Item
Date of Administration
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
time of administration
Item
Time of Administration
time
C1317775 (UMLS CUI [1])
Item Group
Dose#2
C3174092 (UMLS CUI-1)
time of administration
Item
Time of Administration
time
C1317775 (UMLS CUI [1])
Item Group
Dose#3
C3174092 (UMLS CUI-1)
time of administration
Item
Time of Administration
time
C1317775 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial